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Exploring ecological modelling to 
investigate factors governing the 
colonization success in nosocomial 
environment of Candida albicans 
and other pathogenic yeasts
Laura Corte1, Luca Roscini1, Claudia Colabella1, Carlo Tascini2, Alessandro Leonildi2, 
Emanuela Sozio3, Francesco Menichetti2, Maria Merelli4, Claudio Scarparo5, Wieland Meyer6, 
Gianluigi Cardinali1,7 & Matteo Bassetti4
Two hundred seventy seven strains from eleven opportunistic species of the genus Candida, isolated 
from two Italian hospitals, were identified and analyzed for their ability to form biofilm in laboratory 
conditions. The majority of Candida albicans strains formed biofilm while among the NCAC species 
there were different level of biofilm forming ability, in accordance with the current literature. The 
relation between the variables considered, i.e. the departments and the hospitals or the species and 
their ability to form biofilm, was tested with the assessment of the probability associated to each 
combination. Species and biofilm forming ability appeared to be distributed almost randomly, although 
some combinations suggest a potential preference of some species or of biofilm forming strains for 
specific wards. On the contrary, the relation between biofilm formation and species isolation frequency 
was highly significant (R2 around 0.98). Interestingly, the regression analyses carried out on the data of 
the two hospitals separately were rather different and the analysis on the data merged together gave 
a much lower correlation. These findings suggest that, harsh environments shape the composition of 
microbial species significantly and that each environment should be considered per se to avoid less 
significant statistical treatments.
Candida bloodstream infection (BI) is an important cause of morbility and mortality in health care settings and 
represents the fourth cause of nosocomial sepsis in the USA and in most developed countries1,2. Candidemia 
is responsible for unacceptable percentages of attributable and overall mortality rate ranging from 30–81% 
and from 5–71%3, respectively. The incidence of candidemia rose in the last decades of the 20th century due to 
several risk factors4. Candida albicans remains the most common species causing BI, followed by several “non 
Candida albicans Candida species” (NCAC) among which Candida glabrata, Candida parapsilosis and Candida 
tropicalis are usually the most common and show increasing incidence5–7. The various species are a further 
factor to interpret the origin of infection, in fact C. albicans, C. glabrata and C. tropicalis are considered pre-
dominantly commensal and therefore more present in cases of endogenous infections. On the contrary, species 
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found in the natural and anthropic environment, as C. parapsilosis, Meyerozyma guilliermondii (telomorph of 
C. guilliermondii) and Wickerhamomyces anomalus, are more present in exogenous infections8. The recent find-
ing that medical and food isolates of M. guilliermondii cluster differently, according to the ITS and LSU markers, 
poses the question on whether the exogenous infection is caused by strains of the nosocomial environment or of 
other niches9. The increasing frequency of NCAC species has been extensively reported in the last years4,6,10–13 
with significant epidemiological and ecological differences among various geographic areas7,14. This situation 
represents a serious threat, complicated by a significantly lesser knowledge of biofilm and resistance mechanisms 
in NCAC then in C. albicans.
The ability of some fungal species to form biofilm is considered an important factor for their persistence on 
medical devices15,16, and in general in the nosocomial environment17, however, the actual extent of the fungal 
persistence in the hospital is still unclear. Furthermore, the fungal biofilm displays higher resistance to drugs18–20, 
with a complex and yet not totally understood mechanism7, involving the Hsp90, a protein also responsible for 
cell dispersion21, making the biofilm a system to persist in harsh environments and resist to the associated stresses.
From what briefly reported above, the biofilm forming ability represents a severe risk factor1,22 and adds more 
problems to the need of a timely and appropriate therapy to reduce the mortality23.
Altogether, Candida infections represent a serious problem and their ability to form biofilm seems to represent 
not only a medical, but also an ecological problem. In fact, the infecting cells can be present in different niches 
spanning from the devices to the surfaces, the air, some foods and the patients themselves. The cell circulation 
in the environment is an essential point to understand the complex ecology represented by the interaction of 
fungal cells with patients, different substrates and drugs. Furthermore, only a good ecological insight can lead to 
the actual possibility of “catching” these pathogens in their actual niches before the infection. In fact, once the 
infection occurred there are relatively few therapeutics to treat these diseases successfully, whereas environmen-
tal treatments with harsh biocidal compounds can be effective and decrease significantly the incidence and the 
mortality caused by these fungi.
With the above rationale, the present study has been designed around two hypotheses: i. the hospital and the 
various departments, i.e. specific environments, are key factors for the frequency of candidemias; ii. the ability to 
form biofilm has a measurable effect on the incidence of these diseases.
For this purpose, 277 strains of eleven Candida species have been isolated from the various departments of 
two Italian hospitals (Pisa and Udine) 450 km apart, identified at the species level and tested for biofilm formation.
Results
Distribution of the studied characters. Species in the hospitals and wards. Four species were isolated 
in both hospitals: C. albicans, C. glabrata, C. parapsilosis and C. tropicalis (Fig. 1, panel a,b). In the Pisa hospital 
were isolated specifically Pichia kudriavzevii (telomorph of Candida krusii), C. rugosa and some strains yet to be 
attributed to a possibly new yeast species (hereinafter referred to as Candida. spp) (panel a). The species isolated 
uniquely in Udine were Clavispora lusitaniae (telomorph of Candida lusitaniae), C. sake, Cyberlindnera jadinii 
(telomorph of Candida utilis) and Meyerozyma guilliermondii (telomorph of Candida guilliermondii) (panel b). 
The four most represented species present in both hospitals accounted for 86.36% and 96.81% in Pisa and Udine 
hospitals, respectively. As expected, C. albicans was the most frequently isolated species (panel c), absent only 
from the Rehabilitation department of Pisa (panel d). The second most frequent species was C. parapsilosis, fol-
lowed by C. glabrata and C. tropicalis. These data are in good agreement with the current literature24,25. The 
departments with the highest incidences were the specialized medicine, Surgery and ICU in Pisa, while general 
medicine in Udine was by far the ward with more isolations, followed by specialized medicine, Surgery and ICU 
(panel d,e). Merging those data produced a picture very similar to that described for Udine from which came 188 
out of the 276 strains analyzed in this study (panel f).
Biofilm forming strains in hospital departments. The various departments in the two hospital under study 
showed different frequencies of biofilm forming strains (Fig. 2). Namely, in Pisa the Rehabilitation ward had only 
non-biofilm forming isolates, whereas the other four departments showed frequencies ranging from 60 to more 
than 80% (panel a). The situation in Udine was more variable with frequencies of biofilm forming strains ranging 
from 20% (Rehabilitation) to 80% (Surgery) (panel b). Merging the data from the two hospitals gave a synthetic 
view with biofilm forming strain frequency ranging from less than 20% (Rehabilitation) to the 75% of the Surgery 
departments (panel c).
Biofilm forming strains and species. The four prominent species (C. albicans, C. glabrata, C. parapsilosis and 
C. tropicalis) showed different levels of biofilm forming ability, whereas the lesser present species (C. rugosa, P. 
kudriavzevii, C. jadinii, C. sake, C. lusitaniae and M. guilliermondii) did not produce biofilm (Fig. 2, panel f). 
C. albicans biofilm forming strains (hereinafter referred to as BF, in contrast with non BF referred to as NBF) 
were 97.78% and 87.71% in Pisa and Udine, respectively (panels d,e). Since these figures are particularly high, 
the biofilm formation test was repeated with two different methods using XTT and Tetrazonium Blu as indica-
tors, obtaining no significant differences (data not shown). C. glabrata showed quite different frequencies of BF 
strains in Pisa (25%) and in Udine (4.3%), similarly C. tropicalis had all BF strains in Pisa and some 55% in Udine. 
Finally, C. parapsilosis showed 35% and 57% in Udine and Pisa, respectively. In general, Pisa had 75% BF strains 
and Udine 63.63%.
Contingency analysis studied characters. Species vs. hospital departments. Different opportunistic 
yeast species can be distributed randomly in the various hospital departments or show specific preferences for the 
environment represented by the various wards. In order to test the null hypothesis, i.e. that species are distributed 
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randomly within the hospital, a two-way contingency analysis was carried out, following the rationale described 
in Legendre & Legendre26, as outlined in the Experimental Procedures section. This analysis is the gold standard 
in ecological studies when non continuous qualitative data are employed, as in our case, and allows to calculate 
the probability associated to the χ2 (p-value) to accept or reject that the association between species and hospital 
department are independent. When two descriptors are non-independent, then their combination is indicative 
of some sort of specific occurrence. This test was carried out considering the two hospitals separately and then by 
merging all data for a joint analysis (Table 1).
The general χ2 test for the two-way contingency table, obtained with the data of the Pisa hospital, showed no 
statistical significance (p = 0.32), indicating that the distribution of the yeast species was largely due to random 
effect. However, the frequency of C. rugosa in the ICU, and of Candida. spp in the Rehabilitation ward, were sig-
nificantly non independent with 0.0489 and 0.0049 p-values, respectively. These data suggested that these species 
Figure 1. Species presence in the two hospitals studied and relatively frequency of isolation of the different 
species in the hospitals wards. 
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have a certain level of specificity for these environments. Almost significant (p = 0.11741) was the frequency of 
isolation of C. tropicalis in the Surgery department (panel a).
The general χ2 test carried out with all the data from the Udine hospital gave 0.1189 p-value indicating inde-
pendence between species and wards, assuming p = 0.10 as the minimum for statistical significance. However, 
the frequency of isolation of M. guilliermondii in Oncohematology and Rehabilitation showed high χ2 values 
corresponding to p = 0.081 and p = 0.0011, respectively.
C. tropicalis in Onchohaematology showed a significantly non-independence with p = 0.0002. Interestingly, 
three species (C. albicans, C. parapsilosis, C. tropicalis) in the Surgery ward displayed elevated χ2 values with p 
values ranging from 0.17 to 0.22, indicating that their frequency of isolation cannot be entirely ascribed to a ran-
domness (panel b).
Merging the data of the two hospitals, the general χ2 test was significant with p = 0.00819, indicating that the 
hypotheses of random distribution of the species in the departments of the two hospitals can be rejected. In fact, 
several species-department combinations showed high and significant χ2 values, such as C. tropicalis in Surgery 
and Oncohaematology and M. guilliermondii in Rehabilitation and Oncohaematology (panel c). The difference 
between the χ2 tests of the two hospitals considered separately and then jointly can be ascribed to the fact that 
merging all data together produces larger numbers and a consequently more solid statistics. Interestingly, expect-
able random effects explain the frequency of isolation of the various species (null hypothesis) only in the special-
ized medicine departments. C. tropicalis was overrepresented in Oncohaematology and underrepresented in the 
Surgery department (p = 0.0504 and 0.0016 respectively). M. guilliermondii was isolated with a frequency higher 
than expected in Rehabilitation and Oncohaematology (p = 0.0002 and 0.022 respectively), although the absolute 
frequencies are low, that is typical for this rather ubiquitous species found on fruit9.
Most of the cases in which the frequency of isolation were different than expected (null hypothesis rejected) 
interested mostly the less representative species which account for ca. 13% in Pisa and 3% in Udine Hospitals. 
Based on this observation, the cases of statistically supported over- and under-isolation represent only few cases, 
maybe of little epidemiological importance. Yet these preferences are worth better insight, because these few cases 
could underline yet to be described phenomena of preferential environmental (nosocomial) colonization.
Biofilm forming strains vs. hospital departments. The question on whether the biofilm forming strains can 
dwell preferentially in some hospital departments was addressed with the same contingency approach as above 
Figure 2. Relative occurrence of biofilm forming capability in different hospital departments and 
distribution of biofilm forming strains among species. 
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(Table 1). The general χ2 test for the two-way contingency table, obtained with the data of the Pisa hospital, 
showed no statistical significance (p = 0.44), once again indicating that the combination of biofilm forming 
strains and hospital departments were largely due the randomness. In fact, no combination showed p values 
below 0.10 (panel d). On the contrary, in the Udine hospital, the χ2 test was associated with p = 0.0607, indi-
cating that the frequencies of biofilm forming strains and the various departments of isolation cannot be con-
sidered totally independent. Although no combination showed significant p values below 0.10, some weak 
signal of non-independence existed for those departments with less biofilm to isolates as in Rehabilitation and 
Oncohaematology of the Udine hospital ( p = 0.11 and 0.14, respectively) (panel e).
Merging the two datasets led to a two-way contingency table for which the hypothesis of independence can-
not be rejected (p = 0.14). In general, these tests indicated the frequency of isolation of biofilm forming strains is 
based on the randomness, with some significant non independence for the combinations of the Udine hospital 
presented above (panel f).
Biofilm forming strains vs. species. The χ2 analysis of two-way contingency tables between the frequency of bio-
film forming strains and species allowed to reject the null hypothesis with p = 3 × 10−8, 8.7 × 10−6 and 7.2 × 10−22 
for Pisa, Udine and merged data, respectively. This extremely high statistical significance indicates that the fre-
quency of isolation of the single species is influenced by their ability to form biofilm. More specifically, in the Pisa 
hospital, the random effect could be excluded for the BF strains of Candida spp. and for the NBF isolates of C. 
glabrata, C. tropicalis and Candida. spp. Particularly interesting the fact that C. glabrata had three times more NBF 
than expected on the basis of a random effect. In Udine, BF and NBF strain frequencies were significantly associ-
ated with C. albicans, C. parapsilosis and C. glabrata. Namely, C. albicans had 28% more BF than expected, while 
C. glabrata and C. parapsilosis had respectively 14 times more and 50% less BF strains than expected. The situation 
a) Pisa Sp. Med. Surgery ICU Gen. Med. Rehabilit. d) Pisa BF NBF g) Pisa BF NBF
C. albicans 0.98 0.84 0.72 0.59 0.47 Sp. Medicine 0.80 0.66 C. albicans 0.39 0.13
C. glabrata 0.56 0.58 0.90 0.54 0.76 Surgery 0.81 0.68 C. glabrata 0.15 0.01
C. parapsilosis 0.74 0.93 0.93 0.33 0.69 ICU 1.00 1.00 C. parapsilosis 0.39 0.13
C. tropicalis 0.15 0.12 0.77 0.62 0.75 Gen. Medicine 0.81 0.68 C. tropicalis 0.22 0.03
Candida spp 0.20 0.32 0.73 0.43 < 0.01 Rehabilitation 0.39 0.13 Candida spp 0.08 0.01
P. kudriavzevii 0.31 0.60 0.60 0.79 0.92 P. kudriavzevii 1.00 0.32
C. rugosa 0.39 0.46 0.05 0.71 0.88 C. rugosa 1.00 0.16
b) Udine Gen. Med. ICU Sp. Med. Surgery Oncohemat. Rehabilit. e) Udine BF NBF h) Udine BF NBF
C. albicans 0.77 0.83 0.76 0.22 0.17 0.55 Gen. Medicine 0.85 0.81 C. albicans < 0.01 < 0.01
C. glabrata 0.79 0.52 0.29 0.76 0.64 0.62 ICU 0.82 0.76 C. glabrata < 0.01 < 0.01
C. parapsilosis 0.91 0.97 0.25 0.17 0.67 0.92 Sp. Medicine 0.92 0.89 C. parapsilosis 0.04 0.01
C. tropicalis 0.77 0.32 0.48 0.20 < 0.01 0.59 Surgery 0.31 0.18 C. tropicalis 0.72 0.63
M. guilliermondii 0.71 0.60 0.46 0.50 0.08 < 0.01 Oncohematology 0.26 0.14 M. guilliermondii 0.17 0.07
C. lusitaniae 0.46 0.76 0.67 0.70 0.79 0.87 Rehabilitation 0.22 0.11 C. lusitaniae 0.43 0.30
C. sake 0.46 0.76 0.67 0.70 0.79 0.87 C. sake 0.43 0.30
L. jadinii 0.46 0.76 0.67 0.70 0.79 0.87 L. jadinii 0.43 0.30
c) Udine & Pisa Sp. Med. Surgery ICU Gen. Med. Rehabilit. Oncohemat. f) Udine & Pisa BF NBF j) Udine & Pisa BF NBF
C. albicans 0.96 0.33 0.73 0.90 0.43 0.20 Sp. Medicine 0.65 0.52 C. albicans < 0.01 < 0.01
C. glabrata 0.20 0.66 0.85 0.52 0.69 0.71 Surgery 0.46 0.29 C. glabrata < 0.01 < 0.01
C. parapsilosis 0.32 0.29 0.97 0.84 0.97 0.62 ICU 0.93 0.90 C. parapsilosis 0.03 < 0.01
C. tropicalis 0.33 0.05 0.58 1.00 0.51 < 0.01 Gen. Medicine 0.89 0.84 C. tropicalis 0.67 0.54
Candida spp 0.43 0.08 0.15 0.08 0.07 0.52 Rehabilitation 0.13 0.03 Candida spp 0.22 0.08
P. kudriavzevii 0.12 0.66 0.70 0.55 0.88 0.83 Oncohematology 0.21 0.07 P. kudriavzevii 0.41 0.24
C. rugosa 0.49 0.54 < 0.01 0.40 0.84 0.76 C. rugosa 0.25 0.10
M. guilliermondii 0.39 0.45 0.51 0.96 < 0.01 0.02 M. guilliermondii 0.16 0.04
C. lusitaniae 0.62 0.66 0.70 0.27 0.88 0.83 C. lusitaniae 0.41 0.24
C. sake 0.62 0.66 0.70 0.27 0.88 0.83 C. sake 0.41 0.24
L. jadinii 0.62 0.66 0.70 0.27 0.88 0.83 L. jadinii 0.41 0.24
Table 1.  Probabilities associated with the χ2 statistics calculated on contingency tables. Legend. Data are 
probability values associated with the χ 2 statistics and assess the hypothesis that the relationship between the 
two descriptors is random. When the probability value is low the null hypothesis of independence is rejected 
and therefore the combination between the two descriptors is not considered random but caused by some 
phenomenon. p values below 0.10 are reported in boldface; all data have been rounded to the second decimal 
digit. Sp. Med: Specialized Medicine; ICU: Intensive Care Unit; Gen. Med.: General Medicine; Rehabilit: 
Rehabilitation; Oncohaemat.: Oncohaematology; BF: Biofilm Forming; NBF: Non Biofilm Forming.
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of both hospitals considered together was substantially similar to that of Udine, given the preponderance of the 
strains deriving from that hospital.
Modelling the biofilm vs. isolation frequencies. The biofilm formation frequency was compared with 
the frequency of isolation of the single species because the combination of these two characters were shown to be 
non-random with extremely high statistical significance. These two descriptors had 98.51% and 97.37% Pearson 
correlation (R) in Pisa and Udine hospitals, respectively. This was confirmed by the linear correlation analysis 
with R2 of 97.04%, and 94.8% for Pisa and Udine, but with two totally different correlation equations. In fact, in 
Udine, the correlation curve could be described by the equation
. .= +Formula 3 IF 0 942 BF 0 0419
in which IF and BF indicate, respectively, the isolation frequency of single species and the biofilm formation fre-
quency. Formula 3 specifies that the frequency of isolation of each species is 94.2% of the frequency of BF strains 
of the same species.
In Udine, the correlation analysis produced the same R2 as in Pisa, but a different equation:
. .= +Formula 4 IF 1 081 BF 0 0392
This equation indicates that in the Udine hospital the frequency of isolation of each yeast species is 108% of its 
frequency of BF strains. This observation indicates that indeed the ability to form biofilm plays a key role in the 
presence of the species in the hospital environment, but with different dynamics in Pisa and Udine. It was there-
fore not surprising that the correlation analysis of the Pisa and Udine data merged together produced an inter-
mediate situation, described by Formula 5 with a lower R2 (60.94%) than those obtained with the two hospitals 
analyzed separately.
. .= =Formula 5 IF 0 4005 BF 0 0002
The differences between the two hospitals can be pin-pointed by comparing the IF/BF ratio of the single 
species. C. albicans showed 103% and 114% IF/BF ratios in Pisa and Udine respectively. This means that, given a 
frequency of BF C. albicans strains, the probability of isolating this species in Pisa is slightly lower than in Udine. 
C. parapsilosis had 175% and 283% IF/BF ratios in Pisa and Udine, showing that the biofilm forming ability 
influences the frequency of isolation more in Udine than in Pisa. A similar situation was observed for C. tropicalis 
with 100% and 183% IF/BF ratios in Pisa and Udine. Finally, C. glabrata showed 400% and 2300% IF/BF ratios 
in the two hospitals, making it the species for which the biofilm formation ability has the maximum effect on the 
frequency of isolation.
Discussion
The distribution of opportunistic species of the genus Candida presented in this work is largely in accordance 
with the current literature. In fact, the number of isolates of C. albicans ranged from 51–61% in Pisa and Udine, 
showing figures similar to those previously reported5,25. C. tropicalis and C. parapsilosis showed 12.5% average 
frequency and C glabrata 10.6% with a significant difference from the 20% of the formers and the 5% of the latter 
recently reported in Brazil7. The seven species isolated in only one of the two hospitals showed low frequencies 
around 1%, again in accordance with most of the current literature27. These differences can be justified by the 
different geographic places where the studies were carried out, and by a general increase of NCAC species vs 
C. albicans14, indicating that epidemiological data differ significantly over the time and the geography. The ques-
tion on how the geography and the hospital ward influence these species frequencies is difficult to address, due 
to a literature concentrating either on aggregated data or on specific wards, with very few papers reporting the 
distribution within the hospital. This suggests that more detailed reports will be necessary in future to track these 
aspects.
Candida infections have an endogenous origin based on the growth of the cells already dwelling on or in the 
body of the patient as a commensal, while the exogenous origin derives from the surrounding environment28. 
Early studies on these aspects suggested that different areas of the hospital can be more interested to one of the 
two types of Candida infection29. Exogenous nosocomial infections can be triggered by the ability of these fungi 
to persist in the environment, by forming biofilm. Kramer and colleagues30 reported ca 4 months persistance for 
C. albicans and C. glabrata, whereas these figures dropped to a few days according to an older study31. The persis-
tence of C. parapsilosis was estimated on a couple of weeks by the above two studies. There is currently little if any 
information on whether the cells move as pieces of biofilm (sessile cells) or as planktonic cells liberated during the 
maturation of the biofilm and in their way to colonize another surface, initiating a new biofilm plaque32. In both 
cases, dispersed cells have showed enhanced adherence and produce a more robust biofilm than planktonic cells 
not deriving from a biofilm33. The biofilm architecture and resistance varies among species34–37 and sometimes 
with the genetic setting38, making any generalization quite difficult. The whole situations seems to be further com-
plicated by the diversity of resistance mechanisms in young and mature biofilms, whereas the former is relatively 
well elucidated and based on multidrug pumps, the latter seems based on a dormancy mechanism leading to the 
production of “persister” cells5,24,25,39. The fungal biofilm displays higher resistance to drugs18–20, with a complex 
and yet not totally understood mechanism7, involving the Hsp90, a protein also responsible for cell dispersion21. 
The double function of this protein suggests that the complex regulation of the biofilm formation40 is responsible 
for dissemination and resistance: two key factors for the success of these cells in the hospital environment.
The Biofilm forming ability has been suggested as one of the major risk factors for mortality due to C. albicans1 
and in general to the other yeast species analyzed in this article7. However, it seems that, in some settings, the bio-
film forming ability does not increase the mortality nor the probability of getting catheter related candidemia16.
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The study of the factors facilitating the formation of biofilm is an important and little investigated aspect22 to 
understand whether the biofilm formation is triggered by the environmental conditions. In this paper, we have 
considered different hospital departments to test if they have an influence in the biofilm formation. The contin-
gency analysis has shown that there is no differential effect of the various departments in the presence of biofilm 
forming strains. Some instances, such as the Oncohematology of Udine, showed less biofilm than expectable. 
The statistical significance of these variations is relatively good when considering the aggregated data of the two 
hospitals (p = 0.031), whereas there is not significance when considering the disaggregated data of Udine alone. 
This suggests that we have only hints of an effect exerted by some departments, but higher number of strains for 
each hospital will be necessary for a careful determination of the statistical significance.
In our analytical conditions, C. albicans, C. tropicalis, C. parapsilosis and C. glabrata formed biofilm in 90%, 
75%, 42% and 10% of the isolates with 67% among all the studied strains. These figures are in agreement with a 
recent study carried out in Scotland, in which the biofilm formation was reported as quartiles of the spectropho-
tometric quantification after Crystal Violet staining1. The high and intermediate producers accounted for 67%, 59 
and 100% of the C. albicans, C. tropicalis and C. parapsilosis strains, whereas in both cases C. glabrata produced 
biofilm poorly. Interestingly, the high and intermediate producers reported for these three species in this study 
match exactly with the 67 of biofilm formers of our investigation. The differences in the portion of biofilm formers 
within the various species can be due to different environmental conditions.
These high levels of BF vs NBF strains can be due to at least three causes: the environment or the niche, meth-
ods and clonality. The study of the environmental effect is of great importance in these infections, very often 
caused by exogenous environmental contaminations. The other two factors, briefly outlined below, can seriously 
interfere with the effective determination of environmental effects on biofilm formation. The Crystal Violet, the 
XTT and the SYTO9 methods showed correlations ranging from 0.8 to 0.4, meaning poor R2 regression val-
ues ranging from 0.64 to 0.161. This fact indicates that the three methods yield rather independent measures of 
biofilm formation and the results obtained with different methods can diverge significantly. The clonality can 
account for the same strain being isolated repeatedly as different isolates. This problem has not an easy solution, 
because very accurate analyses are necessary to rule out the hypothesis of two strains being identical. Even the 
current barcode marker ITS41 is scarcely effective differentiating isolates and combinations with more marker 
genes can be necessary to address the clonality problem effectively9,42. Until more light will not be shaded on this 
issue, we can only state that the isolates of these studies are very frequently able to form biofilm, regardless of their 
genetic relationships.
In the two hospital studied, the ability to form biofilm was directly correlated with the different frequency of 
the various isolated species according to solid linear correlations. The regression between species frequencies and 
biofilm formation studied separately in the two hospitals had better R2 (0.97 and 0.95 for Pisa and Udine, respec-
tively) than when all data were merged together (R2 = 0.6).
This evidence indicates that the dynamics governing yeasts biofilm presence in the two hospitals considered 
are quite different. Although this situation cannot be generalized on the basis of a single study, care should be 
taken in epidemiological studies to analyze the data pertinent to the specific place from which they derive by 
condensing data because merging data from different environments (hospitals, cities etc.) might be induce serious 
bias.
Biofilm formation is considered of paramount importance in medicine and in a number of environmental 
applications. Altogether, this study has demonstrated that, in the two hospitals analyzed, the biofilm is the major 
factor triggering the persistence of the yeast species in these environments. A number of questions are still open, 
as the problem of clonality and the definition of a comprehensive working model to explain the role played by 
biofilm in persistence, resistance and spreading of the cells in the four most common opportunistic pathogens of 
the genus Candida.
The finding that biofilm formation can be an important factor to favor the presence of microbial cells in harsh 
environments further improves its general and applied biological importance.
Methods
Strains and growth condition. 277 strains belonging to opportunistic species of the Candida genus, iso-
lated in a clinical (medical) environment, were employed in this study (Tables S1 and S2, Supplementary mate-
rials). All strains were isolated from patient bloodcultures, with the exception of C tropicalis 6184a and 6184b 
isolated from peritoneal fluid, C. parapsilosis 6551 from pharyngeal swab and C. albicans 8158 and 8158/C from 
vascular prosthesis. Isolates are kept frozen at − 80 °C in 17% glycerol. Short term storage was carried out on 
YEPDA (YEPD added with 1.7% agarose) at 4 °C. Strains were grown in YEPD (Yeast Extract 1%, Peptone 1%, 
dextrose 1% - all products from Biolife- http://www.biolifeitaliana.it/) at 37 °C with 150 rpm shaking.
Molecular analysis ITS and bioinformatics tools. Genomic DNA was extracted as indicated by Cardinali 
et al.43. ITS1, 5.8S, ITS2 rDNA genes were amplified with FIREPol® Taq DNA Polymerase (Solis BioDyne, Estonia), 
using ITS1 (5′ -TCCGTAGGTGAACCTGCGG) - ITS4 (TCCTCCGCTTATTGATATGC) primers.
The amplification protocol was carried out as follows. Initial denaturation at 95 °C for 4 min, 35 amplification 
cycles (94 °C for 1 min, 53 °C for 1 min and 72 °C for 1 min) and final extension at 72 °C for 10 min. Amplicons 
were purified with the GFX PCR DNA purification kit (GE Healthcare) and subject to electrophoresis on 1.5% 
agarose gel (Gellyphor, EuroClone, Italy). Amplicons were sequenced in both directions with ABI PRISM tech-
nology by MACROGEN (www.macrogen.com) with the same primers used for the generation of the amplicons. 
Consensus sequences for each strain and trimming of the ends with low sequencing quality were carried out with 
Geneious R6 (v. 6.17, Biomatters, Auckland, New Zealand, www.geneious.com). ITS-based species identification 
was carried out with BLAST search44 in GenBank (www.ncbi.nlm.nih.gov/genbank/) and refined with specialized 
databases, RefSeq45 and ISHAM-ITS reference database (ref. 46).
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Biofilm protocol. Biofilm activity was assessed with an XTT method47 and using Resazurin with slight mod-
ification on the XTT protocol. Briefly, each strain was grown over night in bottles containing YEPD (Yeast Extract 
1%, Peptone 1%, Dextrose 2% - Difco Laboratories, USA) medium, at 30 °C in an orbital shaker at 150–180 rpm 
and then harvested and centrifuged at 3,000 × g for 5 minutes at 4 °C. The supernatant was removed and the 
pellet was washed twice with PBS. Washed cells were then resuspended in RPMI-1640 medium (Sigma Aldrich), 
previously warmed at 37 °C, in order to obtain a final density of 1.0 × 106 cells/mL. 100 μ L of this standardized 
cell suspension were seeded in each selected well of 96-well microtiter plate; the wells on column 12 remained 
unseeded, in order to act as negative background control for the subsequent steps.
The microtiter plate was closed, sealed and incubated for 24 h at 37 °C. After biofilm formation, the medium 
in each well was removed carefully with a multi-channel pipette, taking care of not disrupting the biofilm; each 
well was subsequently washed three times with PBS. After each washing step, the plate was drained in an inverted 
position by blotting with paper towels.
Using a multichannel pipette, 100 μ l of fresh 0.001 mg/mL resazurin solution was added to each well of the 
drained plated, included the negative control wells, to assess the biofilm formation. After 1 h incubation at 37 °C, 
the plate was visually inspected to highlight the presence of pink color gradient, resulting from the reduction of 
the blue dye resazurin to the pink dye resorufin by living biofilm-forming cells. Both systems produced quite 
similar results. Strains were considered able to form biofilm when a visible color change was detectable.
Statistical data analysis. Contingency analysis and chi squared test. Contingency analysis and chi squared 
test is the gold standard approach in ecology for the treatment of qualitative non-continuous data, as those 
treated in this paper. Contingency analysis was carried out according to Legendre & Legendre26, as detailed in 
Supplementary materials and depicted in the four parts of Table S3.
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